The point-of-care molecular diagnostics market is projected to reach US$ 5,381.18 million by 2028 from US$ 2,230.94 million in 2021; it is expected to grow at a CAGR of 13.4% from 2021 to 2028.
The global market size of Point of Care (PoC) Molecular Diagnostics is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the end of 2024 with a CAGR of XX% from 2019 to 2024.
Point of care molecular diagnostics market is expected to reach a market value of USD 5.12 billion by 2027 growing at a CAGR of 12.9% in the forecast period of 2020-2027. The growing awareness regarding the testing methods among patients has been directly impacting the growth of point of care molecular diagnostics market.
Global Point of Care Technology Market Information by Product Type (Glucose Testing, Cardiac Markers, Hb1Ac Testing, Coagulation), by Instrument (Blood Glucose Meter), by End User (Clinics, Hospital, Home Care, Ambulatory Care) - Forecast to 2027
The global point of care diagnostics market was valued at US$ 17,886.3 Mn 2018 and is expected to reach US$ 30,175.3 Mn 2026, growing at a CAGR of 6.8% during the forecast period.
Increasing government initiatives to promote the use of Point of Care Testing products and the rise in the geriatric population are driving the demand of the market.
Data Bridge Market Research analyses that the point of care molecular diagnostics market is expected to undergo a CAGR of 13.40% during the forecast period https://www.databridgemarketresearch.com/reports/global-point-of-care-molecular-diagnostics-market
iGATE Research has released a research report on “Global Point of Care Testing Market (By Diagnostics Segment, Mode, End Users, Regions), 100 Company Profiles - Forecast to 2025” Click here to view the complete report: www.igateresearch.com Contact US iGATE Research PVT LTD Ravi Sinha Sales Manager Marketing and Sales Divison Email: ravi.sinha@igateresearch.com Contact: +91-858-684-0791, +91-821-092-7469 (INDIA) Web: www.igateresearch.com
Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027
Request a case study or sample research report @ https://precisionbusinessinsights.com/request-sample?product_id=17104 The Global Point of Care Diagnostics market size was valued at USD 27.66 billion in the year 2020 and is anticipated to record a CAGR of 3.25% during the overcast period 2021-2027. Competitive Analysis: Industry players follow some effective strategies to increase the revenue share in the market. A few of the prominent key players operating in point of care diagnostics market include Siemens AG (Germany), Abbott Laboratories, Inc.
The Global Point Of Care Diagnostics Market size was valued for $22,975 million in 2015 and is expected to reach $43,336 million by 2022, growing at a CAGR of 9.4% from 2016 to 2022. The point of care (POC) diagnostics defined in this report are the medical devices used to get an immediate result in the investigation (diagnosis & monitoring) of various diseases such as cancer, diabetes, cardiac diseases, and others. Request sample copy of this report at: https://www.alliedmarketresearch.com/request-sample/161
Point-of-care testing is mostly used in the hospitals and clinical centres for effective patient care in the trauma care and emergency department. The main tools used after the test in are to measure ration as blood gas and electrolyte in the body. Additionally, rapid testing by POC diagnostic technologies is expected to shorten the duration of surgical procedures.
This TriMark Publications report “Point of Care Diagnostic Testing World Markets” describes latest developments in the point of care testing market segment. For more details : http://goo.gl/6pZ2p8
Point-of-care coagulation testing devices market is projected to expand at a CAGR of ~6% during the forecast period, leading players in the market focus on new products with multiple modes and features, which will be more efficient and deliver a new level.
Increasing occurrence of infectious and respiratory diseases, surging geriatric population across the globe, rising demand of home health care facilities along with advanced products, increasing expenditure from government and private institutions, growing focus on decentralised diagnosis are some of the factors that will enhance the growth of the point of care molecular diagnostics market in the forecast period of 2020-2027
Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive.
The molecular point of care diagnostics market is estimated to grow at a CAGR of 14.05% and expected to reach $7398.82 million by 2028. Get a Free Sample Report.
A new market study based on the Point Of Care Diagnostics Market designed from various sources which also include porter's five forces analysis research techniques to explore the new opening of the market for the period of 2019-2025. The study also interrogates and examines the information based on share, market size, growth path, and the latest trends to recognize the potential value of the market. And most importantly, the data on the current business scenario will also help players to understand the stakeholder strategies and discover the new opportunities which will help them to succeed in their way.
Global Point of Care Diagnostics (POC) Market Analysis By Product, By Application, And Segment Forecasts To 2020 is a latest Medical Devices Industry report.
Global Point of Care Testing Market is expected to reach USD 35.3 billion by 2024 from USD 18.6 billion in 2016, growing at a CAGR of 8.4% in the forecast period 2017 to 2024.
Allied Market Research has recently published a report on the point of care diagnostics market, which is a comprehensive study of the entire industry for the period of 2014–2022.
Research Beam added report on “Global Medical Automation Technologies Market 2015 - 2022”. The Global Medical Automation Technologies Market is estimated to be $48.4 billion in 2014 and is expected to reach $95.2 billion growing at a CAGR of 8.82% from 2014 to 2022. The factors that are influencing the market growth include rising healthcare costs, investment by venture capitalists and the increase in use of point of care testing devices (glucose meters, digital blood pressure monitors, pregnancy test kits and HIV test kits). However the tax imposed by the U.S government on medical devices manufacturers and rigorous approval procedures to launch a product or services by companies is likely to hinder the market growth. The rising need of automation in various other medical fields represents the growth opportunities for this market. Enquiry @ http://www.researchbeam.com/global-medical-automation-technologies-outlook-2014-2022-market/enquire-about-report
Point-of-care Cholesterol Monitoring Device Market: Inclination Towards Portable Devices & Increasing Cholesterol Home Testing Trending the Global Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028
The Report on “Point of Care POC Testing Market Size, Share, Growth, Profit, Analysis, Trends and Strategy 2015" added by Research Beam Enquiry about report: http://www.researchbeam.com/2015-emerging-point-of-care-poc-testing-cancer-clinics-ambulatory-centers-surgery-centers-nursing-homes-birth-centers-supplier-shares-volume-and-sales-forecasts-for-300-tests-market/enquire-about-report
Point-of-care testing is mostly used in the hospitals and clinical centres for effective patient care in the trauma care and emergency department. The main tools used after the test in are to measure ration as blood gas and electrolyte in the body. Additionally, rapid testing by POC diagnostic technologies is expected to shorten the duration of surgical procedures.
Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories.
The Point of Care Diagnostic Devices Market has changed the game because earlier, a medical sample had to be sent away from the patient for hours, sometimes for days, before the results were known. During this delay, the patient has to be treated without the necessary information.
Big Market Research “Global Medical Automation Technologies Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-medical-automation-technologies-outlook-2014-2022-market The report “Global Medical Automation Technologies Market” is the result of an in-depth analysis by market professionals with valuable inputs from industry experts. The report offers a comprehensive insight into the recent business overview, current and future market trends, key drivers and restraints along with detailed segmentation and forecast. The global medical automation technologies market was evaluated at $48.4 billion in 2014 and would reach $95.2 billion registering 8.82% CAGR during 2014-2022.
Avail more information from Sample Brochure of report @ http://tinyurl.com/gre5az9 This new 1,230-page report contains 343 tables, and provides a comprehensive analysis of the 10 major POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies. Read analysis @ http://tinyurl.com/jklw5v3
[191 Pages Report] Biosensors market research report categorizes global market by application (point of care, home diagnostics, research labs, biodefense, environmental monitoring, food industry), product (wearable, non-wearable), technology (electrochemical, piezoelectric, optical) & geography
Vegetable Farming Global Market Report 2018 Including: Peppers; Potatoes; Lettuce; Tomatoes; Sweet corn; Broccoli; Onions; All Other vegetables, provides a comprehensive analysis of global vegetable farming market, leading players, leading countries in global vegetable farming, consumer’s point of view, smart farming, market for global vegetable farming, farming technology and equipment, and future of global vegetable farming. To know more, visit https://www.kenresearch.com/agriculture-and-animal-care/farming/vegetable-farming-global-market-report/143758-104.html
Infectious Diagnostics Rapid & Point of Care Tests Pipeline Review, 2015 provides an overview of Infectious Diagnostics Rapid & Point of Care Tests currently in pipeline stage. Enquiry about report: http://www.researchbeam.com/infectious-diagnostics-rapid-and-point-of-care-tests-pipeline-review-2015-market/enquire-about-report
In vitro diagnostics (IVD) are diagnostic tests practiced in an artificial environment. The overall revenue of the Asia-Pacific IVD market accounted for about $10.7 billion in 2014, and is estimated to reach $15.3 billion by 2020, registering a CAGR of 6.5% over the forecast period. Check complete report @ http://www.marketintelreports.com/report/allied0076/in-vitro-diagnostics-ivd-asiapacific-market--opportunities-and-forecasts-2014--2020
[191 Pages Report] Biosensors market research report categorizes global market by application (point of care, home diagnostics, research labs, biodefense, environmental monitoring, food industry), product (wearable, non-wearable), technology (electrochemical, piezoelectric, optical) & geography
The biosensor is a sensing device, which consists of a combination of a specific biological element and a transducer. This market is expected to witness a prominent growth over the coming years. Driven by the need for better methods for environmental monitoring and rapid pathogen detection, the biosensors industry has also been expanding to encompass non-clinical applications such as biodefense, environmental surveillance, and food industry.
The concept of Point of Care Testing (POCT), also known as bedside, near-patient testing and decentralized testing, relates to tests that are conducted by clinical operators at the site of patient care where immediate medical action is taken on the results. The fact that point of care (POCT) represents a departure from conventional laboratory medicine has created new opportunities in the field of diagnostics industry. Technical advancements over recent years have helped point of care testing (POCT) to grow with double digit CAGR from 2009 to 2011 and evolve into a vital diagnostic tool. It is predicted that point of care testing market will be approximately US$ 25 Billion by 2016.
Visit at: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-infectious-disease-testing-supplier-shares-and-country-forecasts-market Research Beam’s report on 2015-2019 Future Horizons and Growth Strategies in the US Point-of-Care/POC Infectious Disease Testing Market: Supplier Shares and Country Forecasts” contains 61 tables, and provides a comprehensive analysis of the POC infectious disease testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
[452 Pages Report] Point-Of-Care Diagnostics / Testing Market report categories the Global market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
Visit: http://www.researchbeam.com/2015-2019-future-horizons-and-growth-strategies-in-the-us-point-of-care-poc-hematology-and-flow-cytometry-supplier-shares-and-country-forecasts-market Research Beam provides report on Future Horizons and Growth Strategies in the US Point-of-Care/POC Hematology and Flow Cytometry Markets 2015-2019, a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.
The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028
The death care services market size is expected to significantly grow at a CAGR of more than 7.5% during the forecast period. The growth in the death care services market is due to the digital revolution and leading vendors investing in premium products and services to serve the boutique consumers. Read Report https://www.thebusinessresearchcompany.com/report/death-care-services-global-market-report
The diabetes care devices market size is expected to reach nearly $35 billion in 2021 at a compound annual growth rate (CAGR) of slightly more than 7% during the forecast period. The growth in the diabetes care devices market is due to increased government initiatives to help raise awareness of diabetes and adoption of advanced technologies.
The global market for point-of-care (POC) diagnostics to have been almost $15.1 billion in 2012. The market should reach $15.5 billion in 2013 and $19.3 billion in 2018, a compound annual growth rate (CAGR) of 4.5% over the next five years.
The diabetes care devices market size is expected to reach nearly $35 billion in 2021 at a compound annual growth rate (CAGR) of slightly more than 7% during the forecast period.
The diabetes care devices market size is expected to reach nearly $35 billion in 2021, growing at a CAGR of slightly more than 7% during the forecast period. Download A Sample PDF @ http://bit.ly/2Hg4IH8
The diabetes care devices market size is expected to reach nearly $35 billion in 2021 at a compound annual growth rate (CAGR) of slightly more than 7% during the forecast period.Get More Insights @ http://bit.ly/2Hg4IH8
The hospitals and outpatient care centers market size is expected to reach nearly $3700 billion by 2022, growing at a compound annual growth rate (CAGR) of slightly more than 4% during the forecast period.
The global aptamers market was valued at $200 million in the year 2012. At the end of 2013, the market is expected to be $287 million and is poised to reach approximately $2.1 billion by 2018, growing at a CAGR of 49.24% from 2013 to 2018.